Clinical trial
Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients
NCT00489372 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00489372 |
|---|---|
| Title | Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients |
| Official title | Phase I Study of Single Oral Dose of Se-Methyl-Seleno-L-Cysteine (MSC) in Adult Men |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy, no Evidence of Disease |
| Intervention type | Drug, Other |
| Interventions | Se-methyl-seleno-L-cysteine, placebo, pharmacological study, laboratory biomarker analysis |
| Enrollment | 36 |
| Start date | Jul 1, 2007 |
| Primary completion | Mar 1, 2008 |
| Completion | Jul 1, 2009 |
| First posted | Jun 21, 2007 |
| Last update posted | Nov 14, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: